Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

A 47-year-old man was diagnosed with a specific type of hair loss and advised to use certain medications and avoid hair transplants.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Hair loss condition FFA was seen before the appearance of skin depigmentation vitiligo in a patient.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Vitamin A affects hair loss and immune response in alopecia areata.

SLE patients often face depression and anxiety due to physical changes, with African-American and Hispanic patients having higher unmet psychological needs.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Sarcoidosis is more common and severe in Black patients than in Caucasians, requiring early diagnosis and treatment.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Both lasers are equally effective and safe for treating freckles.

Some drugs may help treat both COVID-19 and radiation injury.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

Early treatment and regular check-ups are crucial for lupus patients to prevent progression and improve outcomes.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Melatonin could be an effective treatment for Alzheimer's Disease and rosacea.